$60.55
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. The firm's segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). Its BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research and development solutions in chemical research fields. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and others.
Country

US

CEO

Dr. Frank Laukien

IPO date

2000

Employees

11,085

ISIN

US1167941087

Key stats

Open

$59.99

Volume

1.60M

Market cap

$9.22B

Prev. close

$60.58

Impl / hst vl

-

Open interest

$0.00

$58.94

Day’s Range

$60.62

$32.37

52W Range

$64.54

Valuation

33
Valuation score
Overvalued
P/E
-
P/S
2.64
P/B
3.73
Current ratio
1.55
Debt / Equity
0.63
ROE
-0.51%
Gross margin
47.28%
Income growth
-76.51%
FCF growth
-73.61

Jul

7

Dividends

The last payment date was Jul 7, 2026

Div. per Share

$0.05

Div. Yield

0.08%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 8 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$51.63
The top 17 analysts forecasts that 12-month price may decrease by 14.73%, with a low of $35.35 and a high of $72.45
$35.35
Low
$51.63
Avg
$72.45
High
Current price

Earnings

Q1 ‘26 revenue
$823.40M
Q1 ‘26 net income
$3.50M
Revenue
Net income
Previous EPS
$0.31
Estimate EPS
$0.39
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply